What's Inside


LHI Home
Make a Gift to LHI
Follow LilleheiHrt on Twitter

Apparel Order


  Home > Research > Jennifer L. Hall, PhD, FAHA, FACC - Lab
 

Jennifer L. Hall, PhD, FAHA, FACC - Lab


Photo of Jennifer Hall

Phone: 612.626.3083
FAX: 612.624.8118
Ofc: 612.625.4144
Email: jlhall@umn.edu

LAB: 6th floor NHH

Lab Members:
Jennifer Hall, PhD, Principal Investigator; Neeta Adhikari, PhD, Senior Research Associate; Marjorie Carlson, BS, Research Associate; Kim Ramil Montaniel
Identifying DNA variants in microRNA binding sites in genes that are associated with heart failure.
Defining the role of endogenous heparan sulfate proteoglycans in vascular remodeling.
Determining the genes and signaling pathways associated with recovery from human heart failure
Links

Our interest is to identify genetic variants that are associated with cardiovascular disease and diabetes and define their biological function. We are currently integrating strategies from multiple disciplines to determine how genetic variants alter the course of disease. These strategies incorporate population genetics, biochemistry, cell biology, and transgenic and knockout animals.

Our current projects include:

Identifying DNA variants in microRNA binding sites in genes associated with heart failure

This work is funded by the National Institute of Health and includes bioinformatics approaches, genotyping, microRNA expression and molecular wet lab approaches.

Defining the role of endogenous heparan sulfate proteoglycans in vascular remodeling

Heparan sulfate in vascular structure and remodeling: Following a novel finding that Wnts and TCF7L2 regulate vascular remodeling (Wang et al, Circ Res, 2002), Dr. Hall's laboratory examined the role of heparan sulfate proteoglycans in vascular development and remodeling. In collaboration with Dr. Jeffrey Esko at the University of California-San Diego and Dr. Scott Selleck at Pennsylvania State University, the laboratory uses multiple mouse models to address how alterations in heparan sulfate fine structure affect growth-factor trafficking, vascular development, arterial elasticity, and blood pressure (this work is funded by the National Institutes of Health).

Determining the genes and signaling pathways associated with recovery from human heart failure

Identifying DNA variants associated with altered vascular reactivity in African Americans. Identification of genes with common/rare variants affecting even 1% of the African American population in the United States will account for ~375,000 individuals at risk for hypertension. In order to accomplish this research, we will use state-of-the-art exome sequencing and bioinformatics, a deeply phenotyped collection of samples from the NHLBI Multi-Ethnic Study of Atherosclerosis (MESA), and mechanistic studies in mouse and cellular models.

Links

Internal

LHI Program in Translational Genomics

Developmental Biology Center

Cardiovascular Division

External

NHLBI PRogram for Genomic Applications

The Sanger Institute: Human Genome Project

CardioGenomics: Program for Genomic Applications

back to top


Feedback | Notice of Privacy Practices